ReviewThe New phytologist2026
Making fish oils in plants: from alpha to omega.
Review in The New phytologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic engineering of cereal lipids: from omega-3 fatty acids to wax esters and pheromones.Advanced biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The transgenic accumulation of omega-3 long-chain polyunsaturated fatty acids represents one of the most complex assemblies of heterologous sequences in a plant host. Through the combined efforts of multiple research teams from public and private sectors, GM crops synthesising these important fatty acids have progressed from the initial proof-of-principle stage to fully regulated and approved products. That this has taken over 25 years should not be surprising, but equally, there are several aspects of the sophisticated metabolic engineering which remain unresolved. The aim of this short review is to shine a light on some of the less familiar aspects of these efforts and to maybe prompt renewed consideration of the associated issues. In particular, the oft-ignored topic of transgene silencing in plant biotechnology is considered, as is the potential of multicistronic polyprotein fusions to reduce construct complexity and sequence repetition. Collectively, it is hoped that focussing on these important but neglected topics will inspire a new wave of research activity, underpinning a further shift to a fully sustainable bioeconomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.